Business Objects Licenses Business Intelligence Software to Pfizer

Business Wire, April 2, 2003

Business Editors/High-Tech Writers

SAN JOSE, Calif.--(BUSINESS WIRE)--April 2, 2003

Business Objects (Nasdaq:BOBJ), the world's leading provider of business intelligence (BI) solutions, today announced that global pharmaceutical company Pfizer (NYSE:PFE) has licensed Business Objects business intelligence software for its worldwide research and development division.

Business Objects allows Pfizer to track, understand, and manage information in various ways. Among them: an executive dashboard of key company indicators that highlights revenue, costs, performance and customers; up-to-date finance reports that examine such items as the amount of money spent on business travel, automatically distributed through the finance department; procurement reports that track the timeliness of purchase orders and deliveries; and research and development reports on scientific research.

"Customers from every industry are turning to Business Objects for a simple purpose - to turn their data into an asset which they can use to improve business performance," said Bernard Liautaud, chairman and CEO of Business Objects.

About Business Objects

Business Objects is the world's leading provider of business intelligence (BI) solutions. Business intelligence lets organizations access, analyze, and share information internally with employees and externally with customers, suppliers, and partners. It helps organizations improve operational efficiency, build profitable customer relationships, and develop differentiated product offerings.

The company's products include data integration tools, the industry's leading integrated business intelligence platform, and a suite of enterprise analytic applications. Business Objects is the first to offer a complete BI solution that is composed of best-of-breed components, giving organizations the means to deploy end-to-end BI to the enterprise, from data extraction to analytic applications.

Business Objects has more than 17,000 customers in over 80 countries. The company's stock is publicly traded under the ticker symbols NASDAQ: BOBJ and Euronext Paris (Euroclear code 12074). It is included in the SBF 120 and IT CAC 50 French stock market indexes. Business Objects can be reached at 408/953-6000 and www.businessobjects.com.

Company and product names may be trademarks of the respective companies with which they are associated.